• Bayer, Loxo Partner Up For $1.5B Cancer Drug Development pharmamanufacturing
    November 15, 2017
    Bayer and Loxo Oncology have announced plans to work together to develop and commercialize two cancer therapies in a deal that potentially brings Loxo up to $1.55 billion over the coming few years. 
PharmaSources Customer Service